Molecular and Cellular Analysis of Breast Cancer

Stanford University1 site in 1 country145 target enrollmentSeptember 10, 2014

ConditionsBreast - Female Breast - Male

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Breast - Female
Sponsor: Stanford University
Enrollment: 145
Locations: 1
Primary Endpoint: levels of GM-CSF in plasma
Status: Completed
Last Updated: 5 months ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of the study is to investigate the different types and subtypes of cells found in breast tumors. The investigators will do this using a variety of molecular analysis tools that may allow for improved tests. The different types of cells in breast cancer impacts the way individuals respond to various treatments.

Registry

clinicaltrials.gov

Start Date

September 10, 2014

End Date

April 19, 2021

Last Updated

5 months ago

Study Type

Observational

Sex

Female

Investigators

Sponsor

Stanford University

Responsible Party

Principal Investigator

Kathleen Horst

Kathleen Horst MD

Stanford University

Eligibility Criteria

Inclusion Criteria

•Histologically proven diagnosis of breast cancer or a carcinoma of unknown primary consistent with the presentation of a primary breast malignancy.
•18 years of age or older.
•Ability to understand and the willingness to sign a written informed consent do

Exclusion Criteria

Not provided

Outcomes

Primary Outcomes

levels of GM-CSF in plasma

Time Frame: 10 years

We will be measuring levels of GM-CSF (Granulocyte-macrophayge colony stimulating factor) from the plasma of the patient before during and after the irradiation treatment to study if there is any increase in the GM-CSF production